Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Immunologic Deficiency Syndromes 1IgA Deficiency 1

Interventions

Cell Count 1B-Cell Activating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Immunologic Deficiency Syndromes × B-Cell Activating Factor × Clear all
NCT00024934 2016-09-22

B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
20 enrolled

Immunologic Deficiency Syndromes, Neoplasms, IgA Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡